Although a substantial proportion of cancers harbor wild‐type (wt) p53, its function is found inactivated or at least inhibited (Burgess et al., 2016; Wade et al., 2013), mainly by the murine double minute (MDM) proteins, MDM2 and MDMX (or MDM4). This evidence concerns the gene TP53 and cancer.